Feasibility of brain tumor delineation using immunolabeled gold nanorods
Publication
, Journal Article
Seekell, K; Lewis, S; Wilson, C; Grant, G; Wax, A
Published in: Optical Molecular Probes Imaging and Drug Delivery Omp 2013
January 1, 2013
The enhanced scattering of gold nanorods in the near-infrared regime provides excellent contrast for imaging within biological tissues. This study demonstrates the capability of anti-EGFR nanorods to distinguish xenograft glioblastomas from healthy murine brain tissue. ©2013 The Optical Society (OSA).
Duke Scholars
Published In
Optical Molecular Probes Imaging and Drug Delivery Omp 2013
DOI
Publication Date
January 1, 2013
Start / End Page
MW1C.3
Citation
APA
Chicago
ICMJE
MLA
NLM
Seekell, K., Lewis, S., Wilson, C., Grant, G., & Wax, A. (2013). Feasibility of brain tumor delineation using immunolabeled gold nanorods. Optical Molecular Probes Imaging and Drug Delivery Omp 2013, MW1C.3. https://doi.org/10.1364/omp.2013.mw1c.3
Seekell, K., S. Lewis, C. Wilson, G. Grant, and A. Wax. “Feasibility of brain tumor delineation using immunolabeled gold nanorods.” Optical Molecular Probes Imaging and Drug Delivery Omp 2013, January 1, 2013, MW1C.3. https://doi.org/10.1364/omp.2013.mw1c.3.
Seekell K, Lewis S, Wilson C, Grant G, Wax A. Feasibility of brain tumor delineation using immunolabeled gold nanorods. Optical Molecular Probes Imaging and Drug Delivery Omp 2013. 2013 Jan 1;MW1C.3.
Seekell, K., et al. “Feasibility of brain tumor delineation using immunolabeled gold nanorods.” Optical Molecular Probes Imaging and Drug Delivery Omp 2013, Jan. 2013, p. MW1C.3. Scopus, doi:10.1364/omp.2013.mw1c.3.
Seekell K, Lewis S, Wilson C, Grant G, Wax A. Feasibility of brain tumor delineation using immunolabeled gold nanorods. Optical Molecular Probes Imaging and Drug Delivery Omp 2013. 2013 Jan 1;MW1C.3.
Published In
Optical Molecular Probes Imaging and Drug Delivery Omp 2013
DOI
Publication Date
January 1, 2013
Start / End Page
MW1C.3